Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 15, 2019

SELL
$14.59 - $23.84 $46,688 - $76,288
-3,200 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$11.23 - $19.1 $24,706 - $42,020
2,200 Added 220.0%
3,200 $61,000
Q3 2017

May 03, 2018

BUY
$15.41 - $32.17 $15,410 - $32,170
1,000
1,000 $18,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Prentiss Smith & CO Inc Portfolio

Follow Prentiss Smith & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prentiss Smith & CO Inc with notifications on news.